Contact Number +27 43 748 4901|General Information: Fiona (fiona@gio.co.za)       Login       Create a login       STEP BY STEP GUIDE TO THE NEW GIO
Therapeutics

The following substances may be provided by an optometrist with a section 22A(15) permit.

Schedule 0

Substance:

Paracetamol

Indication:

Mild pain

Route of administration:

Oral

 

Schedule 1

Substance:

Ibuprofen

Indication:

Mild pain

Route of administration:

Oral

 

Schedule 2

Substance:

Mupirocin

Indication:

Impetigo (eyelids); external hordeolum; infected atopic dermatitis

Route of administration:

Topical application

Substance:

Antazoline

Indication:

Allergic and atopic conjunctivitis

Route of administration:

Topical application

Substance:

Tetrazoline

Indication:

Minor ocular irritation; red eye

Route of administration:

Topical application

Substance:

Oxymetazoline

Indication:

Minor ocular irritation; red eye

Route of administration:

Topical application

Substance:

Cetirizine; loratidine; levocetrizine

Indication:

Atopic dermatitis involving the eyelids

Route of administration:

Oral

Substance:

Sodium cromoglycate

Indication:

Vernal keratoconjunctivitis

Route of administration:

Topical application

Substance:

Hydrocortisone

Indication:

Dermatitis, ectopic or seborrhoeic eczema

Route of administration:

Topical application

 

Schedule 3

Substance:

Atropine

Indication:

Cyclopegic refraction; treatment of uveitis

Route of administration:

Topical application (drops)

Substance:

Tropicamide

Indication:

Cyclopegic; mydriatic

Route of administration:

Topical application (drops)

Substance:

Cyclopentolate

Indication:

Cyclopegic; mydriatic

Route of administration:

Topical application (drops)

Substance:

Homatropine

Indication:

Cyclopegic; mydriatic

Route of administration:

Topical application (drops)

Substance:

Pilocarpine

Indication:

Acute glaucoma

Route of administration:

Topical application (drops)

Substance:

Timolol

Indication:

Acute glaucoma

Route of administration:

Topical application (drops)

 

Schedule 4

Substance:

Chloramphenicol

Indication:

Bacterial conjunctivitis; anterior blepharitis; posterior blepharitis

Route of administration:

Topical application

Substance:

Tetracycline

Indication:

Chlamydial conjunctivitis; blepharitis

Route of administration:

Topical application

Substance:

Erythromycin

Indication:

Chlamydial conjunctivitis; blepharitis; impetigo
(Not to be used as 1st line treatment)

Route of administration:

Topical application

Substance:

Aciclovir

Indication:

Conjunctivitis; Herpes simplex blepharitis: epithelial keratitis

Route of administration:

Topical application

Substance:

Tetracaine

Indication:

Diagnostic aid

Route of administration:

Topical application (drops)

 

Substance:

Oxybuprocaine and other equivalent local anaesthetics

Indication:

Diagnostic aid

Route of administration:

Topical application (drops)